Robert Sidonio: Prophylaxis with Wilate and The WIL-31 Study Results
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Congrats to my co-authors and Octapharma on this wonderful paper focused on the results of type 3 VWD and prophylaxis with Wilate.”
Title: Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL-31 Study Sub-Analysis
Authors: Claudia Djambas Khayat, Leonid Dubey, Adlette Inati, Toshko Lissitchkov, Dzmitry Novik, Elina Peteva, Robert F. Sidonio Jr, Ali T. Taher, Kateryna V. Vilchevska, Vladimir Vdovin, Ana Boban
Read the Full Article on European Journal of Haematology

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 15, 2026, 14:11Alba Maiques Diaz: Completion of My Tenure in the YoungEHA Committee at the EHA
-
Jun 15, 2026, 13:51Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
-
Jun 15, 2026, 13:37Katja Sockel: EHA 2026 Inspires New Ideas and Global Connections
-
Jun 15, 2026, 13:25Srishti Goyal։ India’s Blood Donation Journey – Looking Beyond the Numbers
-
Jun 15, 2026, 13:22Debra BenAvram: Every Two Seconds – Someone Needs Blood
-
Jun 15, 2026, 13:13Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
-
Jun 15, 2026, 13:05Angelo Zanniti: Back from EHA 2026 Congress
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026